找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Breast Cancer; I. Craig Henderson Book 1992 Springer Science+Business Media New York 1992 adjuvant therapy.cell.clinic

[復(fù)制鏈接]
樓主: frustrate
31#
發(fā)表于 2025-3-26 21:36:06 | 只看該作者
Aircraft Prior Based on Primary Radar Data,lue of adjuvant systemic therapy in the management of at least some subsets of these patients has now been widely accepted. These two developments have resulted in many patients being treated with both breast-conserving therapy and adjuvant systemic therapy.
32#
發(fā)表于 2025-3-27 03:59:38 | 只看該作者
Algorithms for Influence Diagramsoposed for palliation of advanced disease or for adjuvant purposes. This approach generally allows the clinician to achieve higher response rates for longer relapse-free periods than with either modality used singly. In spite of these interesting results, it appears that the benefit, at best, is simply additive [.].
33#
發(fā)表于 2025-3-27 07:41:11 | 只看該作者
34#
發(fā)表于 2025-3-27 10:09:44 | 只看該作者
Kanti V. Mardia,Vysaul B. Nyirongong-term survival are almost exclusively dependent upon effective cytotoxic treatments. In diseases such as operable breast cancer, for which adjuvant cytotoxic and endocrine therapies have demonstrated a modest but statistically significant reduction in mortality [.], subjective toxic effects of tre
35#
發(fā)表于 2025-3-27 15:40:40 | 只看該作者
Bayesian Networks and Decision Graphsbeen spilled in debating the best name for a field whose contribution to therapy is still ill defined. Both by virtue of primacy and the existence of a periodic, international conference on ‘neo-adjuvant chemotherapy,’ this term has achieved the widest acceptance. Other terms remain in use, however,
36#
發(fā)表于 2025-3-27 19:59:57 | 只看該作者
37#
發(fā)表于 2025-3-28 00:30:00 | 只看該作者
38#
發(fā)表于 2025-3-28 03:23:23 | 只看該作者
Adjuvant chemotherapy of axillary lymph-node-positive breast cancerf-Erkrankungen besprochen.?.Dieses Lehrbuch richtet sich an Studierende der Ern?hrungswissenschaften, der Biochemie und Molekularbiologie sowie der Biologie. Zahlreiche Farbabbildungen unterstützen die Wissensv978-3-662-65341-8978-3-662-65342-5
39#
發(fā)表于 2025-3-28 07:30:06 | 只看該作者
40#
發(fā)表于 2025-3-28 10:41:49 | 只看該作者
Models for weighing benefits and toxicitieskers to make diet adjustments and ensure the goals of therapy are met..The 2nd edition is an updated and more extensive version covering the nutrition management of IMD, and covers a wide range of t978-3-030-94509-1978-3-030-94510-7
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 03:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鄢陵县| 偏关县| 宁乡县| 吉隆县| 吉水县| 阿拉善左旗| 平罗县| 青田县| 霍林郭勒市| 刚察县| 襄汾县| 石楼县| 冀州市| 资源县| 叶城县| 乐山市| 灵石县| 巫溪县| 寻甸| 亳州市| 崇文区| 贵溪市| 石楼县| 万安县| 定南县| 金塔县| 林西县| 本溪市| 阿坝县| 萨迦县| 巍山| 凤台县| 重庆市| 新巴尔虎右旗| 玉田县| 保康县| 微山县| 布拖县| 南充市| 龙里县| 甘孜县|